Table 2.
Sociodemographic and baseline variables for analysis per protocol (PP). Italicized P values are significant.
| Characteristics | PP | |||||||||
|
|
TSTMa (n=31) | TCb (n=24) | CGc (n=34) | Chi-square (df) | Kruskal-Wallis (df) | P value | ||||
| Gender(female), n (%) | 4 (12.9) | 5 (20.8) | 16 (47.1) | 10.222 (2) | N/Ad | .006 | ||||
| Age (years), mean (SD) | 14.3 (2.246) | 13.81 (1.939) | 14.83 (2.479) | N/A | 2.310 (2) | .31 | ||||
| Birthplace (Spain), n (%) | 30 (96.8) | 21 (87.5) | 33 (97.1) | 2.938 (2) | N/A | .23 | ||||
| Adoption, n (%) | 2.316 (4) | N/A | .68 | |||||||
|
|
Adopted | 1 (3.2) | 2 (8.3) | 2 (5.9) |
|
|
|
|||
|
|
Shelter home | 0 (0) | 0 (0) | 1 (2.9) |
|
|
|
|||
| ADHDe diagnosed, n (%) | 1.800 (2) | N/A | .41 | |||||||
|
|
Inattentive | 17 (54.8) | 11 (45.8) | 13 (38.2) |
|
|
|
|||
|
|
Combined | 14 (45.2) | 13 (54.2) | 21 (61.8) |
|
|
|
|||
| Medication, n (%) | 16.8 (10) | N/A | .08 | |||||||
|
|
Elvanse | 21 (67.74) | 15 (62.5) | 26 (76.47) |
|
|
|
|||
|
|
Medikinet | 6 (19.35) | 2 (8.33) | 3 (8.82) |
|
|
|
|||
|
|
Equasym | 3 (9.68) | 1 (4.17) | 2 (5.88) |
|
|
|
|||
|
|
Rubricon | 0 (0) | 2 (8.33) | 2 (5.88) |
|
|
|
|||
|
|
Stratera | 0 (0) | 3 (12.5) | 0 (0) |
|
|
|
|||
|
|
Concerta | 0 (0) | 0 (0) | 2 (5.88) |
|
|
|
|||
aTSTM: The Secret Trail of Moon.
bTC: Therapeutic Chess.
cCG: control group.
dN/A: not applicable.
eADHD: attention-deficit/hyperactivity disorder.